The Journal of Experimental Medicine
Keystone Symposia
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20061890
Boissonnas et al.

Figure S1 OT1 cell are activated in the draining lymph node.

Figure S2 OT1 T cell expansion in secondary lymphoid organs.

Figure S3 High TCR down-regulation of OT1-GFP cells occurs in the antigen-expressing tumors.

Figure S4 Analysis of the four categories of migrating OTI cells.

Figure S5 Histological analysis procedure.

Figure S6 Tumor vascularization.

Figure S7 Infiltration of nonspecific T cells.

Figure S8 Density of OT1 cells in MCA-OVA and MCA tumors.

Video 1 Migration of CTLs within an EG7 tumor during the early phase.

Video 2 Migration of CTLs within an EL4 tumor during the early phase.

Video 3 Migration of CTLs within an EG7 tumor during the late phase.

Video 4 Migration of CTLs within an EL4 tumor during the late phase.

Video 5 CTL interactions with EG7 tumor cells during the early phase.

Video 6 CTL interactions with EG7 tumor cells during the late phase.

Video 7 Shape modifications of CTLs within an EG7 tumor during the late phase.

Video 8 CTL division within an EG7 tumor.

Video 9 CTL interactions with blood vessels.

Video 10 CTL interactions with blood vessels.

Video 11 CTL migration along blood vessels.

Video 12 Shape modifications of CTLs in contact or not with blood vessels.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS